TABLE 2.
Human specificity control sera tested by polyvalent rWNV-E MIA
| Specimen type | n | Mean P/N ratio ± SD (range) | No. (%) of specimens with a P/N ratio of:
|
|
|---|---|---|---|---|
| >4.0 | >5.0 | |||
| HSV infection | 5 | 1.77 ± 1.00 (0.64-2.83) | 0 | 0 |
| EBV infection | 5 | 1.44 ± 0.52 (0.92-2.31) | 0 | 0 |
| Syphilis panel 1a | 10 | 21.22 ± 15.9 (1.15-41.1) | 8 (80) | 7 (70) |
| Syphilis panel 2b | 10 | 5.62 ± 10.7 (0.35-32.3) | 2 (20) | 2 (20) |
| CMV infection | 5 | 3.58 ± 2.80 (0.89-7.64) | 2 (40) | 2 (40) |
| HIV infection | 10 | 3.36 ± 5.83 (0.25-19.7) | 1 (10) | 1 (10) |
| B. burgdorferi infection | 10 | 1.77 ± 0.56 (1.09-3.08) | 0 | 0 |
| A. phagocytophila infection | 10 | 1.72 ± 1.05 (0.45-3.78) | 0 | 0 |
| Antinuclear antibody positive | 10 | 0.86 ± 0.41 (0.37-1.63) | 0 | 0 |
| Rheumatoid factor positive | 6 | 0.62 ± 0.34 (0.17-1.11) | 0 | 0 |
| Normal serum | 24 | 2.34 ± 1.26 (0.96-4.82) | 4 (17) | 0 |
| Total | 105 | 17 (16) | 12 (11) | |
a
Rapid plasma reagin positive.
b
T. pallidum particle agglutination positive and rapid plasma reagin RPR negative.